Cargando…
Nasal Mucosa Derived-Mesenchymal Stem Cells from Mice Reduce Inflammation via Modulating Immune Responses
Mesenchymal stem cells (MSCs) have arisen the attention to be a new attractive therapeutic tool treating autoimmune diseases such as allergic rhinitis (AR). AR is a chronic reversible allergic inflammation caused by the excessive activation of T-helper 2 (Th2) cells. Recently, MSCs have been propose...
Autores principales: | Yang, Chen, Li, Jing, Lin, Hai, Zhao, Keqing, Zheng, Chunquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349652/ https://www.ncbi.nlm.nih.gov/pubmed/25739057 http://dx.doi.org/10.1371/journal.pone.0118849 |
Ejemplares similares
-
Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure
por: Xiang, Wen, et al.
Publicado: (2023) -
Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents
por: Watts, Annabelle M., et al.
Publicado: (2019) -
Fibrinolytic components in nasal mucosa and nasal secretion
por: Yasuda, Toyotoshi, et al.
Publicado: (1998) -
Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro
por: Mckinnirey, Flyn, et al.
Publicado: (2021) -
Hypoxic Culture Promotes Dopaminergic-Neuronal Differentiation of Nasal Olfactory Mucosa Mesenchymal Stem Cells via Upregulation of Hypoxia-Inducible Factor-1α
por: Zhuo, Yi, et al.
Publicado: (2017)